Details of the Drug

General Information of Drug (ID: DM2C7S5)

Drug Name

Aerosurf

Indication

Disease Entry	ICD 11	Status	REF
Respiratory distress syndrome	CB00	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04264156) A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks GA. U.S. National Institutes of Health.